Volume 9 Supplement 1
Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase
© Griesberger et al; licensee BioMed Central Ltd. 2009
Published: 11 August 2009
Organic nitrates represent a class of very effective anti-ischemic drugs used for the treatment of angina pectoris, myocardial infarction and congestive heart failure . A limitation of their clinical use is the development of nitrate tolerance. A remarkable exception is the long-acting drug pentaerythrityl tetranitrate (PETN), which was shown to cause no tolerance . The mitochondrial isoform of aldehyde dehydrogenase (ALDH2) was shown to be involved in bioactivation of nitroglycerin (GTN)  and PETN . The present work was carried out to study the molecular mechanisms underlying the pharmacological differences between GTN and PETN at the level of purified ALDH2.
As quantified by liquid chromatography-mass spectroscopy (LC-MS) ALDH2 metabolized 50 μM PETN to 14.84 ± 4.05 nmol/min/mg pentaerythrityl trinitrate (PETriN) in the absence and 62.38 ± 7.21 nmol/min/mg PETriN in the presence of the reducing agent dithiothreitol. Co-incubation of 2 μM [14C]GTN with ALDH2 and increasing concentrations of PETN resulted in only small decreases in 1,2-glyceroldinitrate formation as measured by radio thin layer chromatography (control: 7.98 ± 0.20, 1 μM PETN: 7.95 ± 0.20, 10 μM PETN: 7.41 ± 0.18, 100 μM PETN: 6.66 ± 0.50 nmol/min/mg) indicating that PETN does not compete with GTN metabolism. In the presence of 25 μg of ALDH2 PETN activated soluble guanylate cyclase (sGC) with an EC50 of 3.61 ± 0.35 μM and a maximum at 30 μM PETN (2.67 ± 0.12 μmol/min/mg). This effect was enhanced by superoxide dismutase (SOD) resulting in an EC50 of 0.64 ± 0.08 μM and maximal sGC activation (18.44 ± 0.27 μmol/min/mg in the presence of 30 μM PETN). ALDH2 activity, measured as formation of NADH from NAD+ in the presence of acetaldehyde, was rapidly inactivated by GTN but not by PETN (1 mM each).
Low and high affinity pathways of PETN may explain the apparent differences between PETN metabolism and bioactivation, respectively. The reaction of PETN with ALDH2 leads to activation of sGC with markedly higher values in the presence of SOD suggesting formation of superoxide as a co-product of PETN metabolism. The lack of vascular tolerance to PETN may be due to significantly lower rates of ALDH2 inactivation as compared to GTN.
This work was supported by the Fonds zur Förderung der Wissenschaftlichen Forschung in Austria.
- Daiber A, Oelze M, Wenzel P, Wickramanayake JM, Schuhmacher S, Jansen T, Lackner KJ, Torzewski M, Münzel T: Nitrate tolerance as a model of vascular dysfunction: Roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacol Rep. 2009, 61: 33-48.View ArticlePubMedGoogle Scholar
- Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD: Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol. 2001, 38: 854-859. 10.1016/S0735-1097(01)01414-0.View ArticlePubMedGoogle Scholar
- Chen Z, Zhang J, Stamler JS: Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA. 2002, 99: 8306-8311. 10.1073/pnas.122225199.PubMed CentralView ArticlePubMedGoogle Scholar
- Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mülsch A, Münzel T: Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol. 2004, 66: 1372-1382. 10.1124/mol.104.002600.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.